TNDM Stock Overview
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Tandem Diabetes Care, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$31.73 |
| 52 Week High | US$40.74 |
| 52 Week Low | US$13.82 |
| Beta | 1.13 |
| 1 Month Change | 4.86% |
| 3 Month Change | 37.12% |
| 1 Year Change | -12.66% |
| 3 Year Change | -66.45% |
| 5 Year Change | -48.33% |
| Change since IPO | -83.53% |
Recent News & Updates
At US$30.10, Is Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Worth Looking At Closely?
Mar 26
Even With A 27% Surge, Cautious Investors Are Not Rewarding Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) Performance Completely
Mar 08Recent updates
At US$30.10, Is Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Worth Looking At Closely?
Mar 26Even With A 27% Surge, Cautious Investors Are Not Rewarding Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) Performance Completely
Mar 08Is Tandem Diabetes Care (NASDAQ:TNDM) Using Debt In A Risky Way?
Feb 22Estimating The Intrinsic Value Of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
Jan 14Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Stock Rockets 63% But Many Are Still Ignoring The Company
Dec 27Is It Too Late To Consider Buying Tandem Diabetes Care, Inc. (NASDAQ:TNDM)?
Nov 12Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) Intrinsic Value Is Potentially 53% Above Its Share Price
Oct 06Does Tandem Diabetes Care (NASDAQ:TNDM) Have A Healthy Balance Sheet?
Sep 17Should You Think About Buying Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Now?
Aug 08Calculating The Intrinsic Value Of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
Jul 03Is Tandem Diabetes Care (NASDAQ:TNDM) Using Debt Sensibly?
Jun 13Cautious Investors Not Rewarding Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) Performance Completely
May 06Is Tandem Diabetes Care (NASDAQ:TNDM) Using Debt In A Risky Way?
Jan 04Is Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Potentially Undervalued?
Oct 15Tandem Diabetes Care: Overpriced, Underdelivering
Sep 22An Intrinsic Calculation For Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Suggests It's 50% Undervalued
Sep 10Tandem Diabetes stock falls 10% on disappointing Q2 result
Aug 03Tandem Diabetes Care acquires Capillary Biomedical; terms undisclosed
Jul 21Tandem Diabetes Care: Strong Financials And Revenue, Overpenalized For Missed Earnings
Jul 08Tandem Diabetes Care (NASDAQ:TNDM) Is Looking To Continue Growing Its Returns On Capital
Jun 20Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) Intrinsic Value Is Potentially 43% Above Its Share Price
May 30Here's Why Tandem Diabetes Care (NASDAQ:TNDM) Can Manage Its Debt Responsibly
Apr 17Tandem Diabetes Care: Medical Instruments And Supplies Spell Market Success
Apr 01Shareholder Returns
| TNDM | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -3.7% | -2.9% | -3.2% |
| 1Y | -12.7% | -3.7% | 19.3% |
Return vs Industry: TNDM underperformed the US Medical Equipment industry which returned -3.7% over the past year.
Return vs Market: TNDM underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| TNDM volatility | |
|---|---|
| TNDM Average Weekly Movement | 11.1% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: TNDM's share price has been volatile over the past 3 months.
Volatility Over Time: TNDM's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 2,400 | John Sheridan | www.tandemdiabetes.com |
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company’s flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user’s body.
Tandem Diabetes Care, Inc. Fundamentals Summary
| TNDM fundamental statistics | |
|---|---|
| Market cap | US$2.05b |
| Earnings (TTM) | -US$222.61m |
| Revenue (TTM) | US$747.72m |
2.7x
P/S Ratio-9.2x
P/E RatioIs TNDM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TNDM income statement (TTM) | |
|---|---|
| Revenue | US$747.72m |
| Cost of Revenue | US$380.03m |
| Gross Profit | US$367.69m |
| Other Expenses | US$590.30m |
| Earnings | -US$222.61m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 02, 2024
| Earnings per share (EPS) | -3.45 |
| Gross Margin | 49.18% |
| Net Profit Margin | -29.77% |
| Debt/Equity Ratio | 92.4% |
How did TNDM perform over the long term?
See historical performance and comparison